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Correspondence
Response to Letter Regarding Article, “Peripartum
Cardiomyopathy as a Part of Familial
Dilated Cardiomyopathy”
We thank Dr Baruteau et al for their comments. They raise
an important issue, and recommend cardiological screening in
all first-degree relatives of patients with peripartum cardio-
myopathy (PPCM), not only when it concerns PPCM without
recovery.
Our findings strongly suggested that a subset of PPCM is
part of the spectrum of familial dilated cardiomyopathy.1 The
article by Morales et al2 in the same issue of Circulation
underscores this. Taking these new data into account, we
consider the genetic susceptibility of PPCM properly ad-
dressed in the recent statement from the Heart Failure
Association of the European Society of Cardiology Working
Group on PPCM.3
In our article, we discussed a major limitation of our study:
that we had not performed cardiological screening of family
members of those PPCM patients who had recovered left
ventricular function. We emphasized the importance of study-
ing these cases in the future because they also can be part of
familial cardiomyopathy. This is corroborated by the case
report by Baruteau et al on the occurrence of PPCM in two
sisters with full recovery.4 Besides, apparent recovery is not
always true recovery, because it has been reported that
patients have died during extended follow-up despite recov-
ery of left ventricular function at 6 months’ assessment.5
Thus, we fully agree with Baruteau et al that it is justifiable
to offer cardiological screening to first-degree relatives of
recovered PPCM patients.
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